The objective of this contract is to develop a new chemical entity drug for proteolytic degradation of HIV GAG proteins.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93019C00006
- Awardee
-
Zymeron Corporation UEI GAMMMRQ6QMN1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,794
Award facts
- Opportunity
-
- SBIRPHS20191 Solicitation number
- Nanoparticle Delivery of HIV Env Trimer for Inducing Somatic Hypermutation and bNAb Award Notice · Posted Jun 29, 2018
- Contract value 100% obligated
- $299,794.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $299,794 |
About this award
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Zymeron Corporation, a Minority Owned small business, under the Small Business Innovation Research (SBIR) Program. The objective is to develop a new chemical entity drug for proteolytic degradation of HIV Gag proteins. The contract is a Firm Fixed Price Definitive Contract with a potential value of $299,794.00 and a completion date of May 30, 2021. Zymeron Corporation is a research-based biotechnology company that has provided medical research, engineering services, IT solutions, and innovative biotech products to various federal agencies through SBIR and other contract vehicles. The work will be performed at Zymeron's facilities in Research Triangle Park, North Carolina.
Quick answers
Who was awarded contract 75N93019C00006?
75N93019C00006 was awarded to Zymeron Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 31, 2019.
How much is contract 75N93019C00006 worth?
The government has obligated $299,794 on 75N93019C00006.
Was contract 75N93019C00006 competed?
The extent of competition for 75N93019C00006 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award